The pharmaceutical industry is aggressively evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a peptide hormone, stands as copyrightple of this trend. To fulfill this demand, US-based manufacturing services are emerging. These companies offer